About Halo Pharma
Halo Pharma is a company based in Hanover (United States) founded in 2006 was acquired by Cambrex in July 2018. Halo Pharma offers products and services including Formulation Development, Clinical Supply, Commercial Manufacturing, and Analytical Services. Halo Pharma operates in a competitive market with competitors including Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
- Headquarter Hanover, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Halo Pharma
Halo Pharma offers a comprehensive portfolio of products and services, including Formulation Development, Clinical Supply, Commercial Manufacturing, and Analytical Services.
Services for creating pharmaceutical formulations and testing.
Provision of supplies for clinical trials and registration.
Large-scale production of drug products and packaging.
Laboratory testing for pharmaceutical stability and validation.
Funding Insights of Halo Pharma
Investors in Halo Pharma
Halo Pharma has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Cambrex and SK Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A global private investment firm focused on specialty sectors.
|
Locked | Locked | Locked | |
|
CDMO of complex small molecule APIs, including highly potent APIs
|
Locked | Locked | Locked |
Investor details for Halo Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Halo Pharma
Investment portfolio details for Halo Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Halo Pharma
Detailed financials for Halo Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Halo Pharma Comparisons
Peer comparison for Halo Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Halo Pharma
Halo Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Contract development and manufacturing organization for proprietary and generic drugs
|
|
| Locked | Locked | Locked |
CDMO focusing on spectrum of dosage forms and therapeutic segments
|
|
| Locked | Locked | Locked |
Company offering a suite of R&D and manufacturing services for small molecules and generics
|
|
| Locked | Locked | Locked |
Pharmaceutical development and manufacturing services are offered contractually.
|
|
| Locked | Locked | Locked |
CDMO with a focus on early phase drug product development
|
|
| Locked | Locked | Locked |
Cephalosporin APIs and generic formulations are manufactured.
|
Detailed competitors of Halo Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Halo Pharma
Complete news archive for Halo Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Halo Pharma
Halo Pharma was founded in 2006 and raised its 1st funding round 9 years after it was founded.
Halo Pharma is headquartered in Hanover, United States. It is registered at Hanover, New Hampshire, United States.
Halo Pharmaceutical is a contract development and manufacturing organization which specializes in pediatric dosage forms. Services offered include pharmaceutical development, commercial manufacturing, analytical services for APIs and testing services. Pharmaceutical development services offered include project management, formulation development and analytical development. It has acquired manufacturing facilities from companies like Abbott and Teva to meet the commercial manufacturing needs of its clients by supplying solids, liquids, sterile ointment and packaging services. It also offers chemical and analytical services for pharmaceutical key intermediates and API from development to small-scale commercial production. Testing services offered include chemical and microbiological testing of a complete range of dosage form. Recently, it entered into agreement with Exx pharma to Collaborate on the DevelopmentManufacturing of Products using Twin Screw Extrusion Technology.
Halo Pharma's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Halo Pharma offers Formulation Development, Clinical Supply, Commercial Manufacturing, and Analytical Services.
Halo Pharma has 2 investors. Key investors include Cambrex, and SK Capital.